Isoquinoline derivatives, their preparation and their use
CA 1332944 C · Owner: Novartis Ag · Inventors: Naef, Reto; Hasspacher, Klaus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula I, (I), wherein R1 is hydrogen or C1_4alkyl; R2 is hydrogen and R3 is hydrogen or C1_4alkyl, or R2 and R3 together represent an additional bond as indicated by the dotted line; R4 is hydrogen C1_4alkyl or phenyl; R5 is methoxy or ethoxy; R6 is hydrogen hydroxy, C1_4alkoxy, hydroxy-(C2_4alkoxy) or (C1_4alkoxy)- (C2_4alkoxy); R7 and R8 are each independently C1_4alkoxy or (C1_4alkoxy)-(C2_4alkoxy); and R9 is hydrogen or halogen in free form or pharmaceutically acceptable salt form have, pharmaceutical utility, in particular as bronchodilators eosinophil accumulation and/or activation inhibiting agents and in the treatment or prophylactic treatment of obstructive or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 8, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 8, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.